A new drug (Compound Y) is developed for treatment of cancer. Initial studies on isolated cells show that Compound Y decreases cancer cell viability by 95%. However, when Compound Y is tested on ventricular cardiac myocytes it is observed that it causes a significant reduction in delayed rectifier K+ channel current. Why could Compound Y NOT be taken forward to clinical trials?

Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
icon
Related questions
Question

please choose a right answer from the followng points.

 

A new drug (Compound Y) is developed for treatment of
cancer. Initial studies on isolated cells show that
Compound Y decreases cancer cell viability by 95%.
However, when Compound Y is tested on ventricular
cardiac myocytes it is observed that it causes a significant
reduction in delayed rectifier K+ channel current. Why
could Compound Y NOT be taken forward to clinical trials?
Compound Y is likely to cause a shortening of the Q-T
interval
Compound Y is likely to induce conduction slowing and
QRS prolongation
Compound Y is likely to increase the risk of early
afterdepolarisations (EADS)
Compound Y is likely to trigger spontaneous Ca2+ release
from the sarcoplasmic reticulum (SR)
Compound Y is likely to promote re-entry circuit formation
Transcribed Image Text:A new drug (Compound Y) is developed for treatment of cancer. Initial studies on isolated cells show that Compound Y decreases cancer cell viability by 95%. However, when Compound Y is tested on ventricular cardiac myocytes it is observed that it causes a significant reduction in delayed rectifier K+ channel current. Why could Compound Y NOT be taken forward to clinical trials? Compound Y is likely to cause a shortening of the Q-T interval Compound Y is likely to induce conduction slowing and QRS prolongation Compound Y is likely to increase the risk of early afterdepolarisations (EADS) Compound Y is likely to trigger spontaneous Ca2+ release from the sarcoplasmic reticulum (SR) Compound Y is likely to promote re-entry circuit formation
Expert Solution
steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Substance abuse
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education